A Phase IV, Open-label, Multicenter Study of Treatment With TRIZIVIR (Abacavir 300mg/Lamivudine 150mg/Zidovudine 300mg) Twice Daily and Tenofovir 300mg Once-daily for 48 Weeks in HIV-infected Subjects Experiencing Early Virologic Failure (ZIAGEN Intensification Protocol)
收藏DataCite Commons2024-11-27 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00009176/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
This study is a 48-week study to evaluate the efficacy and safety of an investigational
regimen combining FDA approved HIV drugs in antiretroviral-experienced subjects failing on
their first highly active antiretroviral therapy regimen.
提供机构：
Vivli
创建时间：
2023-08-15
